ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Institute of Biomedical Research Corporation New (PK)

Institute of Biomedical Research Corporation New (PK) (MRES)

0.0085
0.0002
( 2.41% )
Updated: 13:26:53

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.0085
Bid
0.0085
Ask
0.0098
Volume
888,559
0.0083 Day's Range 0.00995
0.0069 52 Week Range 0.028
Previous Close
0.0083
Open
0.00995
Last Trade
98825
@
0.0085
Last Trade Time
13:26:53
Average Volume (3m)
1,097,288
Financial Volume
$ 8,182
VWAP
0.009208

MRES Latest News

MRES: M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board

MRES: M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board CAPE TOWN, SOUTH AFRICA -- July 19, 2023 -- InvestorsHub NewsWire...

MRES: M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Offering Extraordinary Health and Medicinal Benefits

MRES: M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Offering Extraordinary Health and Medicinal Benefits CAPE TOWN, SOUTH AFRICA -- July 14, 2023...

MRES: M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and Altcoins for Drug Discovery, Revolutionizing Investment Access

MRES: M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and Altcoins for Drug Discovery, Revolutionizing Investment Access   CAPE TOWN, SOUTH AFRICA...

MRES: Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing

MRES:  Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing   CAPE...

MRES: M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX

MRES: M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX   CAPE TOWN, SOUTH AFRICA -- June 26, 2023 -- InvestorsHub NewsWire -- Institute of Biomedical...

MRES: M2Bio Sciences Establishes Research Chair at The University of Pretoria for Phytomedicines

MRES: M2Bio Sciences Establishes Research Chair at The University of Pretoria for Phytomedicines CAPE TOWN, SOUTH AFRICA -- June 16, 2023 -- InvestorsHub NewsWire -- Institute of...

MRES: M2Enviro Expands R&D Efforts to Explore Diverse Classes of Mycelium Composite Materials for Commercialization

  MRES: M2Enviro Expands R&D Efforts to Explore Diverse Classes of Mycelium Composite Materials for Commercialization   CAPE TOWN, SOUTH AFRICA -- June 14, 2023...

MRES: Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutions

MRES: Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutions CAPE...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.001-10.52631578950.00950.01090.0074510076870.00882957CS
4000.00850.01490.0074512990180.01033348CS
12-0.0012-12.37113402060.00970.01490.00710972880.00971513CS
26-0.00445-34.36293436290.012950.01690.0079376440.00979448CS
527.5E-50.8902077151340.0084250.0280.006914029930.01535518CS
1560.0069431.250.00160.0450.000212038290.01565406CS
2600.00781114.285714290.00070.0450.000210238390.01442722CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.74
(378.74%)
21.7M
XLOXilio Therapeutics Inc
$ 1.43
(123.79%)
28.47M
CEROCERo Therapeutics Holdings Inc
$ 3.105
(90.49%)
15.67M
BDRXBiodexa Pharmaceuticals PLC
$ 1.5001
(74.63%)
81.92M
KYCHKeyarch Acquisition Corporation
$ 11.7401
(67.59%)
160.21k
BOLDBoundless Bio Inc
 14.74
(-75.42%)
486.09k
PMECPrimech Holdings Ltd
$ 1.41
(-63.66%)
5.89M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
GMDAGamida Cell Ltd
$ 0.0383
(-35.30%)
64.7M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.2239
(-31.51%)
15M
NKLANikola Corporation
$ 1.029
(13.19%)
127.95M
BDRXBiodexa Pharmaceuticals PLC
$ 1.5001
(74.63%)
81.92M
MARAMarathon Digital Holdings Inc
$ 22.885
(3.69%)
66.18M
GMDAGamida Cell Ltd
$ 0.0383
(-35.30%)
64.7M
AKANAkanda Corporation
$ 0.17
(3.09%)
63.33M

MRES Discussion

View Posts
jdcpa1 jdcpa1 2 days ago
Media coverage MRES and RLAB M2MMA...

https://www.thephuketnews.com/m2mma-gets-ready-to-kick-off-in-phuket-91726.php
👍️ 2
longrichard longrichard 3 days ago
LOL
👍️0
LUCKYBUTT LUCKYBUTT 4 days ago
Do some research on how much the MMA sold for in the USA.... You are C******
👍️0
jdcpa1 jdcpa1 4 days ago
You must be one of the clueless that post nonsense while also being long.. The MMA concept will be a beast.. Sell your shares quickly and I will put a bid in for ya.. let me know when your ready...
👍️ 1
creakyhottie creakyhottie 4 days ago
So the company is promoting martial arts so that people can suffer concussions and brain injury, in order to study
its effects.

I get it now.
👍️0
jdcpa1 jdcpa1 4 days ago
It's Game on for MRES and RLAB imo... Sleeping giants and this is only one division of MRES which majority owns and controls RLAB.

"Jeff's Corner: 🪑This Sunday, March 31, in Phuket, Thailand, we will unveil M2MMA1, 🥊🥋 a concept that evolved from dream to reality in six months. This significant event is the first step towards our broader mission to unify and uplift the fragmented Muay Thai community, starting in Phuket and then advancing through Bangkok, Singapore, Asia, and Australia🇹🇭🇸🇬🇦🇦🇺
My ambition for M2MMA transcends traditional Mixed Martial Arts promotions. One of my/our many goals is to build a USD 3 billion enterprise within five years (why 3 billion, it's doable), coupling exhilarating sports with cutting-edge proprietary Big Data and AI technology. This approach is not solely for the sport’s enhancement but is pivotal for gathering critical health data to benefit the global community. Specifically, CTE- Chronic Traumatic Encephalopathy, CTE, is a progressive degenerative disease affecting people who have suffered repeated concussions and traumatic brain injuries that may occur in some athletes and others who have been exposed to concussions and repetitive head impacts.🧠
The upcoming M2MMA Stadium and training facility, The Jungle, 🌴near Phuket’s airport, will be the hub for this innovative mission and provide a foundation for our plans to revolutionize the martial arts sector globally.
Moreover, a core part of our mission is to revolutionize athlete care in the sport. We are committed to providing unprecedented pre-, post, and long-term healthcare for our M2MMA athletes. This initiative ensures their well-being inside and outside the ring, setting new standards in athlete care and support in combat sports. Our holistic approach to athlete welfare will include state-of-the-art medical support, rehabilitation services, and long-term health monitoring, ensuring our fighters receive the highest standard of care, making M2MMA a pioneering force in sports health and entertainment.
I'm pumped; I hope you are as well. 💪❤️
#GoBigorGoHome #peakperformance"
👍️ 4
GREGG THE GREEK GREGG THE GREEK 6 days ago
It is a bit frustrating that we still have someone selling ....especially after the last few days where it APPEARED that the seller had possibly finished.

Far as the spinoff shares are concerned. Many of us were under the impression we'd get some and it's still a possibility if you follow Jeff on Twitter/X.

Might be they want those who stick around to get rewarded vs those who might be in it for the freebies. Still believe we'll be better than fine here w MRES. Though I sure would love to see it begin to base higher.

All jmo.
👍️ 2
wxdog wxdog 6 days ago
Tis my assessment as well. But expanding/growing and making oneself visible = progress.
👍️ 1
creakyhottie creakyhottie 6 days ago
Was pleasant, not great. Does not give a sense of $$$ volume and potential profit.

A break from all the kick boxing tweets.
👍️0
wxdog wxdog 6 days ago
LOL Apparently so. Buy the rumor, sell the news. And it wasn’t “bad” news?
👍️0
creakyhottie creakyhottie 6 days ago
Wxdog
So I guess this morning's seller and the current million share ask size is allergic to
peanut butter
👍️0
wxdog wxdog 6 days ago
https://finance.yahoo.com/news/mres-m2bio-food-beverage-wraps-141500242.html
👍️ 1
SkyTrader7 SkyTrader7 1 week ago
Buyings are coming back in
👍️0
sakingme sakingme 1 week ago
WTF 35% drop in one day. Some real news would be nice.. especially since some misled us here to believe we would receive RLAB stock as part of the MMA deal.
👍️0
Iceman Iceman 2 weeks ago
Glad to see the breakout on the chart yesterday. LTT!

Great times ahead for the months/years to come.

ICE
👍️0
ktcougar ktcougar 2 weeks ago
Agree. The only penny I’m holding at the moment. Still very early here. The story is just starting.

kt
👍️ 1
learningthetruth learningthetruth 2 weeks ago
Finally ready to leave the nest and spread its wings.

$MRES, if anyone has done their Due Diligence here, they know this is worth .10+ and that's conservative and no hype whatsoever. https://t.co/hFCc8AMcco— learningthetruth (@learningdatruth) March 14, 2024
👍️ 1
valleybenedetto valleybenedetto 2 weeks ago
DTC shares only 135 mil. Tiny for OTC. Seller gone , level 2 is thin and Hempcelium division spinoff coming.
👍️ 1
SkyTrader7 SkyTrader7 2 weeks ago
31. March is near. Be sure you have your tickets . M2MMA Phuket
👍️0
SkyTrader7 SkyTrader7 2 weeks ago
Almost only Buyings today
👍️0
mikeo56 mikeo56 2 weeks ago
Fantastic... thanks for posting this information.
👍️ 1
jdcpa1 jdcpa1 2 weeks ago
News!!!!

https://www.einnews.com/pr_news/695929619/rlab-m2mma-is-pleased-to-share-phuket-m2mma1-fight-card-and-updates
👍️ 3
LUCKYBUTT LUCKYBUTT 2 weeks ago
SOMEONE IS LOADING
👍️0
ktcougar ktcougar 2 weeks ago
Starting to trade a little better lately.
👍️ 1
LUCKYBUTT LUCKYBUTT 2 weeks ago
BEST STOCK IN THE OTC IMO
👍️ 1
LUCKYBUTT LUCKYBUTT 2 weeks ago
I saw that too yesterday. Weird
👍️0
clam man clam man 2 weeks ago
What’s with the 670 something shares traded like 25% above the ask price this morning?
👍️0
SecondLife SecondLife 2 weeks ago
Agreed. I keep grabbing them while their cheap. 💪🏻
👍️0
Lottalead Lottalead 2 weeks ago
Just a matter of time before folks realize this is incredibly undervalued. I’m surprised the share price is so low.
👍️ 4 💪 1
sakingme sakingme 2 weeks ago
hmm.. what's happening here? She's rumbling a bit.
👍️0
Jmc1299 Jmc1299 3 weeks ago
Also good to see who ever is selling someone is buying it up I think that’s a good sign of accumulation for somebody
👍️0
Jmc1299 Jmc1299 3 weeks ago
Good to see this moving again I think this giant is starting to wake up from the winter hibernation lol glta
👍️0
creakyhottie creakyhottie 3 weeks ago
nice volume today
👍️0
SkyTrader7 SkyTrader7 3 weeks ago
Website is very powerful. Excellent
👍️0
jdcpa1 jdcpa1 3 weeks ago
M2MMA website has been updated and looks amazing! This trades under RLAB and is majority owned by MRES. With the first M2MMA events about to launch this month, these will bring a lot more eyes onto both RLAB and MRES imo..

https://m2mma.com/
👍️ 1
Jmc1299 Jmc1299 3 weeks ago
I sure hope so
👍️0
pmunch pmunch 3 weeks ago
Somebody knows we goin UP !$! MRES
👍️ 1
Iceman Iceman 3 weeks ago
Somebody wanted more MRES near the end of today....

MRES

ICE
👍️0
pmunch pmunch 4 weeks ago
Well I believe the MRES share count may be lowered even more , like soon

Makes that calculation for MRES even more valuable

Instead of 60, might be closer to 30
👍️ 1
SkyTrader7 SkyTrader7 4 weeks ago
Excellent update
👍️0
Iceman Iceman 4 weeks ago
MRES: M2Bio Sciences Provides Corporate Update
NEWS PROVIDED BY
M2Bio Sciences Food and Beverage (Pty) Ltd
March 01, 2024, 13:29 GMT



Institute of Biomedical Research Corp. (OTCBB:MRES)

CAPE TOWN, WESTERN CAPE, SOUTH AFRICA, March 1, 2024 /EINPresswire.com/ -- Institute of Biomedical Research Corporation (OTC PINK: MRES) is pleased to provide further details of the sale to Real American Capital Corporation (OTC PINK: RLAB) of 100% ownership of the concept, business model, contacts and contracts that collectively can be used to establish a mixed martial arts league and are herein referred to as "M2MMA" (https://m2mma.com).

The transaction was completed and finalized through a complete share-based settlement, leading to a change in control of Real American Capital Corporation. If all preferred shares are converted into common shares, MRES is projected to hold approximately 71% of RLAB's fully diluted shares, with an expected total of 56,368,000 outstanding shares. As a result, investors can gain exposure to RLAB either directly or by holding shares in MRES.

It has been previously disclosed that MRES's CEO, Jeff Robinson, and CFO, Willem Jonker, have been appointed as the Chairman and Chief Financial Officer of RLAB, respectively.

The MRES organogram:
MRES has several divisions that may, after incubation within MRES, be spun out into their own publicly traded entities:

M2Bio Food and Beverage owns and operates three consumer goods brands: Medspresso™, Dr. AnnaRx™, and Liviana™. The brands span many premium CBD-infused consumer goods, including bioceuticals, health and wellness, and precision foods and beverages. With operations currently based in Cape Town, South Africa, the company and its brands are positioned in the high-value market segment. To cement its status within this premium market segment, M2Bio is committed to an unwavering standard of excellence, prioritizing procuring and producing superior-quality components. This includes using pharmaceutical-grade CBD extracts, premium-grade coffees, and the finest extra virgin olive oils, ensuring consistent delivery of unparalleled product quality and consumer experience.

In March 2023, the Company signed a distribution agreement with Innovative Holdings Alliance Inc. to distribute the Company’s products in the United States of America. The Company’s products are well suited to the premium markets in the USA.

Furthermore, MRES has established a landmark collaboration with the University of Pretoria and Enterprises University of Pretoria to inaugurate the M2Bio Sciences Discovery Centre for AI-Driven Phytomedicine Research. This initiative is dedicated to AI-driven phytomedicine research, propelling MRES's ongoing investigations into plant-based medicines and leveraging Artificial Intelligence and Machine Learning in drug discovery and forensic science.

The Centre is set to revolutionize the field with its extensive database of over 15,000 endemic African plants, offering a rich resource for AI applications in pharmaceutical research. In an innovative approach, the Centre will also integrate NFTs and digital tokens to make the drug discovery process more accessible and democratic.

M2Biome encompasses the nutritional and educational facets of M2Bio Sciences, focusing on the critical connection between gut health and overall wellness. A growing body of evidence highlights the importance of nurturing the microbiome through lifestyle choices. M2Biome is dedicated to delivering products grounded in scientific research tailored to meet the diverse needs of individuals while maintaining the highest standards of quality and environmental sustainability. Our commitment lies in relentless innovation, aiming to offer advanced solutions for enhanced well-being.

M2Enviro, a leader in biotechnological innovation and environmental stewardship, spearheads advancements in mycelium technology to develop innovative, sustainable products. This division is committed to transforming material science by providing eco-conscious alternatives to conventional, harmful petroleum-based materials prevalent today. In 2023, our efforts led to significant achievements in research and development, resulting in the launch of our pioneering product, Hempcelium™.

M2Sentient delves into the interplay between the human sensory system and mental health. In the realm of human biology, the sensory modalities—visual (sight), auditory (hearing), tactile (touch), gustatory (taste), and olfactory (smell)—serve as the primary interfaces between the external environment and our internal psychological landscape. These sensory channels are not merely conduits for data; they are integral to our cognitive processing, shaping our perception, emotion, and cognition.

In the psychological context, Sentience denotes the capacity for conscious perception and experience. It embodies the ability to undergo subjective experiences, encompassing awareness and responsiveness to the environment. This concept is a cornerstone of human consciousness, deeply intertwined with sensory input and interpretation.

The exploration of sentience and the sensory mechanisms offers a nuanced understanding of their pivotal roles in shaping human behavior and mental health. By investigating how sensory experiences influence psychological states, M2 Sentient aims to unravel the complex dynamics of human consciousness and develop innovative approaches to mental health treatment, emphasizing the profound connection between our sensory experiences and overall psychological well-being.

M2Bio Kids represents the nascent division within MRES, spearheading an innovative endeavor to optimize mental and physical health during the critical developmental period from infancy through early childhood (up to five years of age). Anchored in the advanced confluence of biotechnological research and pediatric health sciences, M2Bio Kids is positioned to transform early childhood development strategies. This initiative adopts an integrative methodology, focusing on dietary and nutritional interventions, physical activities, cognitive exercises, and enhancing critical thinking skills through AI-driven hardware and software applications. This comprehensive approach fosters holistic growth and development in the early years, setting a foundation for lifelong health and well-being.

Real American Capital Corporation (OTC PINK: RLAB) is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol "RLAB." https://www.otcmarkets.com/stock/RLAB/.

Contact:
Jeff Robinson, CEO
Jeff@m2bio.co
+27 72 333 2148
👍️0
Iceman Iceman 4 weeks ago
MRES: M2Bio Sciences Provides Corporate Update
Friday, 01 March 2024 09:10 AM

ACCESSWIRE | Article Logo
Institute of BioMedical Research Corp.

CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / March 1, 2024 / Institute of Biomedical Research Corporation (OTC PINK:MRES) is pleased to provide further details of the sale to Real American Capital Corporation (OTC PINK:RLAB) of 100% ownership of the concept, business model, contacts and contracts that collectively can be used to establish a mixed martial arts league and are herein referred to as "M2MMA" (https://m2mma.com).

The transaction was completed and finalized through a complete share-based settlement, leading to a change in control of Real American Capital Corporation. If all preferred shares are converted into common shares, MRES is projected to hold approximately 71% of RLAB's fully diluted shares, with an expected total of 56,368,000 outstanding shares. As a result, investors can gain exposure to RLAB either directly or by holding shares in MRES.


It has been previously disclosed that MRES's CEO, Jeff Robinson, and CFO, Willem Jonker, have been appointed as the Chairman and Chief Financial Officer of RLAB, respectively.


The MRES organogram

MRES has several divisions that may, after incubation within MRES, be spun out into their own publicly traded entities:

M2Bio Food and Beverage owns and operates three consumer goods brands: Medspresso™, Dr. AnnaRx™, and Liviana™. The brands span many premium CBD-infused consumer goods, including bioceuticals, health and wellness, and precision foods and beverages. With operations currently based in Cape Town, South Africa, the company and its brands are positioned in the high-value market segment. To cement its status within this premium market segment, M2Bio is committed to an unwavering standard of excellence, prioritizing procuring and producing superior-quality components. This includes using pharmaceutical-grade CBD extracts, premium-grade coffees, and the finest extra virgin olive oils, ensuring consistent delivery of unparalleled product quality and consumer experience.

In March 2023, the Company signed a distribution agreement with Innovative Holdings Alliance Inc. to distribute the Company's products in the United States of America. The Company's products are well suited to the premium markets in the USA.

Furthermore, MRES has established a landmark collaboration with the University of Pretoria and Enterprises University of Pretoria to inaugurate the M2Bio Sciences Discovery Centre for AI-Driven Phytomedicine Research. This initiative is dedicated to AI-driven phytomedicine research, propelling MRES's ongoing investigations into plant-based medicines and leveraging Artificial Intelligence and Machine Learning in drug discovery and forensic science.

The Centre is set to revolutionize the field with its extensive database of over 15,000 endemic African plants, offering a rich resource for AI applications in pharmaceutical research. In an innovative approach, the Centre will also integrate NFTs and digital tokens to make the drug discovery process more accessible and democratic.

M2Biome encompasses the nutritional and educational facets of M2Bio Sciences, focusing on the critical connection between gut health and overall wellness. A growing body of evidence highlights the importance of nurturing the microbiome through lifestyle choices. M2Biome is dedicated to delivering products grounded in scientific research tailored to meet the diverse needs of individuals while maintaining the highest standards of quality and environmental sustainability. Our commitment lies in relentless innovation, aiming to offer advanced solutions for enhanced well-being.

M2Enviro, a leader in biotechnological innovation and environmental stewardship, spearheads advancements in mycelium technology to develop innovative, sustainable products. This division is committed to transforming material science by providing eco-conscious alternatives to conventional, harmful petroleum-based materials prevalent today. In 2023, our efforts led to significant achievements in research and development, resulting in the launch of our pioneering product, Hempcelium™.

M2Sentient delves into the interplay between the human sensory system and mental health. In the realm of human biology, the sensory modalities-visual (sight), auditory (hearing), tactile (touch), gustatory (taste), and olfactory (smell)-serve as the primary interfaces between the external environment and our internal psychological landscape. These sensory channels are not merely conduits for data; they are integral to our cognitive processing, shaping our perception, emotion, and cognition.

In the psychological context, Sentience denotes the capacity for conscious perception and experience. It embodies the ability to undergo subjective experiences, encompassing awareness and responsiveness to the environment. This concept is a cornerstone of human consciousness, deeply intertwined with sensory input and interpretation.

The exploration of sentience and the sensory mechanisms offers a nuanced understanding of their pivotal roles in shaping human behavior and mental health. By investigating how sensory experiences influence psychological states, M2 Sentient aims to unravel the complex dynamics of human consciousness and develop innovative approaches to mental health treatment, emphasizing the profound connection between our sensory experiences and overall psychological well-being.

M2Bio Kids represents the nascent division within MRES, spearheading an innovative endeavor to optimize mental and physical health during the critical developmental period from infancy through early childhood (up to five years of age). Anchored in the advanced confluence of biotechnological research and pediatric health sciences, M2Bio Kids is positioned to transform early childhood development strategies. This initiative adopts an integrative methodology, focusing on dietary and nutritional interventions, physical activities, cognitive exercises, and enhancing critical thinking skills through AI-driven hardware and software applications. This comprehensive approach fosters holistic growth and development in the early years, setting a foundation for lifelong health and well-being.

Real American Capital Corporation (OTC PINK:RLAB) is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol "RLAB." https://www.otcmarkets.com/stock/RLAB/.

Contact:

Jeff Robinson, CEO
Jeff@m2bio.co
+27 72 333 2148
👍️ 1
ktcougar ktcougar 4 weeks ago
Wish they would have spelled it out a little better and given a date. Guess we'll see??

kt
👍️0
ktcougar ktcougar 4 weeks ago
I think this is the link you wanted to post:
https://www.accesswire.com/838150/mres-m2bio-sciences-provides-corporate-update
If all preferred shares are converted into common shares, MRES is projected to hold approximately 71% of RLAB's fully diluted shares, with an expected total of 56,368,000 outstanding shares. As a result, investors can gain exposure to RLAB either directly or by holding shares in MRES.

So MRES holders would have around 40m shares of RLAB. So about 1 share for every 60 shares of MRES? That's just based on OS of 2,371,424,113 divided by 40 million is around 60.
Just off the top of my head......buying 100k of MRES here at .0085($850) gets you 1,666 shares of RLAB trading at .20($333).

kt
👍️0
pmunch pmunch 4 weeks ago
News out $$ MRES RLAB

https://www.einpresswire.com/article/692582141/mres-m2bio-sciences-provides-corporate-update

https://www.accesswire.com/838150/mres-m2bio-sciences-provides-corporate-update
👍️0
pmunch pmunch 4 weeks ago
News: RLAB and MRES : If all preferred shares are converted into common shares, MRES is projected to hold approximately 71% of RLAB's fully diluted shares, with an expected total of 56,368,000 outstanding shares. As a result, investors can gain exposure to RLAB either directly or by holding shares in MRES.

https://www.einpresswire.com/article/692582141/mres-m2bio-sciences-provides-corporate-update

https://www.accesswire.com/836151/mres-m2bio-sciences-introduces-m2biokids-a-pioneering-approach-to-elevating-childhood-health-and-development
👍️ 2 💪 1
clam man clam man 4 weeks ago
Care to elaborate?
👍️0
6of1 6of1 4 weeks ago
you dont really beleive all that bunk do you?
👍️0
creakyhottie creakyhottie 1 month ago
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / February 23, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in alternative plant-based cannabinoids, medical psilocybin, and cutting-edge mental health therapeutic research driven by artificial intelligence (AI), is pleased to announce the following updates:

M2Bio Sciences proudly announces the launch of its groundbreaking new division, M2BioKids, a pioneering initiative dedicated to enhancing mental and physical health in the formative years of life, from newborns to children aged five years. Rooted in the cutting-edge intersection of biotechnology and pediatric health science, M2BioKids is set to revolutionize early childhood development through a comprehensive approach encompassing food, nutrition, physical and mental exercises, and critical thinking via AI-driven apps.


The foundational years of a child's life are crucial for setting the stage for lifelong health, well-being, and cognitive abilities. Recognizing the immense potential for positive impact during this pivotal period, M2BioKids leverages the latest scientific research to develop innovative solutions and strategies to optimize growth, health, and developmental outcomes.

Nutritional Science: At the core of M2BioKids' mission is a deep commitment to advancing nutritional science for young children.


Understanding that proper nutrition is the cornerstone of healthy development, our research focuses on identifying optimal dietary patterns and micronutrient intakes that support brain development, immune system strength, and physical growth. Through the creation of scientifically formulated foods and supplements, M2BioKids aims to address common nutritional deficiencies and promote a foundation of health from the earliest stages of life.

Physical Development: Physical activity is another crucial pillar of M2BioKids' holistic approach. Recognizing the critical role of physical development in early childhood, our programs are designed to encourage age-appropriate motor skills through playful, engaging exercises that promote strength, coordination, and overall physical health. By integrating these activities into daily routines, M2BioKids supports the natural growth process while laying the groundwork for an active, healthy lifestyle.

Mental and Cognitive Enhancement: M2BioKids is equally focused on the mental and cognitive aspects of early childhood development. We aim to stimulate critical thinking, problem-solving, and creativity by developing innovative educational tools and programs. Our approach is rooted in the latest cognitive science, ensuring our methods engage young minds and support neural development, language acquisition, and emotional intelligence.

Research and Development: At the heart of M2BioKids is a robust research and development program committed to pushing the boundaries of what's possible in early childhood health and development. Our multidisciplinary team of scientists, pediatric health experts, and educators collaborate to explore new theories, conduct clinical trials, and translate discoveries into practical applications. This relentless pursuit of knowledge ensures that M2BioKids remains at the forefront of scientific advancement, delivering evidence-based solutions that make a real difference in the lives of children and their families.

Interactive AI-Driven App: M2BioKids is developing an interactive AI-driven app to enhance its impact further. This digital platform will engage children in learning activities while offering parents and caregivers valuable nutrition, physical activity, and cognitive development resources. The app will feature gamified learning experiences, interactive storytime, and movement challenges, making learning fun and educational. Personalized recommendations and developmental milestone tracking will provide a tailored experience that evolves with the child.

Market Need and Innovation: The launch of M2BioKids comes in response to a critical and underserved need in the early childhood development sector. Statistics underscore the global challenge of undernutrition, which is a contributing factor in nearly half of all deaths in children under five, highlighting the urgent need for improved nutritional science and interventions. Additionally, with over 130 million babies born each year worldwide, the demand for holistic, scientifically-backed developmental aids is increasing. M2BioKids addresses these needs by offering innovative solutions that promise to significantly impact the health and development of young children, presenting a compelling and sustainable business segment with extensive growth potential.

Future Directions: As M2BioKids grows and evolves, our vision extends beyond the immediate horizon. We are committed to expanding our research to cover a broader spectrum of childhood development issues, exploring innovative therapies, and developing new technologies that address the complex needs of growing children. With a foundation built on science, compassion, and innovation, M2BioKids is poised to lead a new era in childhood development, impacting future generations.

Jeff Robinson, CEO of M2Bio Sciences, stated: "M2BioKids is a groundbreaking initiative that epitomizes M2Bio Sciences' dedication to harnessing the power of AI, biotechnological innovations, and scientific research to enhance children's mental and physical health. By strategically focusing on the critical developmental windows from preconception through the early years, M2BioKids integrates advanced nutritional science, neurodevelopmental strategies, and pioneering digital tools to establish a robust foundation for lifelong health, cognitive well-being, and intellectual prowess. This approach not only aims to cultivate a generation that is healthier, more intellectually capable, and more adaptable to challenges but also sets a new benchmark in pediatric health science, promising a brighter, more resilient future for children globally."

About Institute of Biomedical Research Corp./ DBA M2Bio Sciences

Institute of Biomedical Research Corp is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin and mental health therapeutic research powered by artificial intelligence, and evidence-based sustainable products and solutions that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™, Liviana™ brands as well as artificial intelligence-powered nutrition products and solutions under the M2Biome brand. In addition, our research and clinical trials with psilocybin are aimed at new therapies to help patients suffering from alcohol addiction, mental illness, and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies such as artificial intelligence.

The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol "MRES."

Publicly traded Company (OTC Pink:MRES)

CONTACT:

www.m2bio.co
jeff@m2bio.co
+27 72 333 2148
👍️0
clam man clam man 1 month ago
Selling pressure??? There was 500k shares traded. And I personally bought 200,000 of them. That’s a no one is buying and no one is selling. It’s a few thousand dollars you banana
👍️ 2 💯 1

Your Recent History

Delayed Upgrade Clock